Abbott Laboratories (NYSE:ABT) reported first-quarter 2026 results that management said were “aligned with our expectations ...

Bill McColl has 25+ years of experience as a senior producer and writer for TV, radio, and digital media leading teams of anchors, reporters, and editors in creating news broadcasts, covering some of ...

Detailed price information for Abbott Laboratories (ABT-N) from The Globe and Mail including charting and trades.

Shares of Abbott Laboratories (ABT) have seen a small negative price reaction in response to a larger deal for its smaller diagnostic peer Exact Sciences Corporation (EXAS), taking place at a revenue ...

The S&P 500 has performed well in 2023, but healthcare stocks have lagged behind. Abbott Laboratories continues to lap difficult comparable quarterly earnings reports, but the core business has been ...

The Food and Drug Administration on Wednesday authorized the first rapid coronavirus test that doesn’t need any special computer equipment to get results. The 15-minute test from Abbott Laboratories ...

Abbott Laboratories cut its full-year earnings outlook to account for a recent acquisition and said its nutrition unit continued to notch soft sales during the first quarter. The company, which sells ...

Abbott Laboratories cut its full-year earnings outlook to account for a recent acquisition and said a weaker-than-expected ...

Abbott Laboratories ABT stock fell on Thursday after the company revised its 2026 earnings outlook below expectations.

Abbott Diabetes Care said it had received reports of more than 700 injuries that may be associated with malfunctioning sensors. By Amanda Holpuch ByHeart, the maker of the product, has been linked to ...